Trying times: an experience of early pandemic COVID-19 diagnosis and enduring long COVID.

https://bit.ly/3A7JCpZ.

Patient experiences of biologic treatment for severe asthma: the good, the outstanding and the deeply frustrating.

https://bit.ly/3DJVmxP.

The discovAIR project: a roadmap towards the Human Lung Cell Atlas.

The Human Cell Atlas (HCA) consortium aims to establish an atlas of all organs in the healthy human body at single-cell resolution to increase our understanding of basic biological processes that govern development, physiology and anatomy, and to accelerate diagnosis and treatment of disease. The Lung Biological Network of the HCA aims to generate the Human Lung Cell Atlas as a reference for the cellular repertoire, molecular cell states and phenotypes, and cell-cell interactions that characterise normal lung homeostasis in healthy lung tissue. Such a reference atlas of the healthy human lung will facilitate mapping the changes in the cellular landscape in disease.

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis.

https://bit.ly/36PZnSL.

The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs.

https://bit.ly/3rrYS9s.

How treatment burden affects the carer: the experiences of three individuals, a mother, a daughter and a husband.

https://bit.ly/3oekJjo.

Women with COPD.

https://bit.ly/2X7Klmd.

Providing answers to respiratory patients' questions during COVID-19.

https://bit.ly/2F5ZP4k.

Survival following the placement of gastrostomy tube in patients with multiple sclerosis.

Background: Around a third of people with multiple sclerosis (MS) experience dysphagia. There is a need for disease-specific information on survival following placement of gastrostomy tube in people with MS.

Objective: We aimed to study survival following gastrostomy in patients with MS.

No Effect of Tart Cherry Juice or Pomegranate Juice on Recovery from Exercise-Induced Muscle Damage in Non-Resistance Trained Men.

Tart cherry juice (TC) and pomegranate juice (POM) have been demonstrated to reduce symptoms of exercise-induced muscle damage (EIMD), but their effectiveness has not been compared. This randomized, double-blind, parallel study compared the effects of TC and POM on markers of EIMD. Thirty-six non-resistance trained men (age 24.